PLUS1
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | 1.79% | 57.00 | 56.00 | 58.00 | 57.50 | 54.50 | 56.00 | 630,662 | 11:11:25 |
| Industry Sector | Turnover (m) | Profit (m) | EPS - Basic | PE Ratio | Market Cap (m) |
|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 1.1 | -20.4 | -55.0 | - | 32 |
Genedrive (GDR) News Headlines
Genedrive News
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/5/2021 | 18:00 | UKREG | Genedrive PLC Block listing Interim Review |
| 28/5/2021 | 16:40 | UKREG | Genedrive PLC Second Price Monitoring Extn |
| 28/5/2021 | 16:35 | UKREG | Genedrive PLC Price Monitoring Extension |
| 06/5/2021 | 14:05 | UKREG | Genedrive PLC Second Price Monitoring Extn |
| 06/5/2021 | 14:00 | UKREG | Genedrive PLC Price Monitoring Extension |
| 30/4/2021 | 10:51 | ALNC |  Genedrive shares surge after Covid test approved by Indian regulator |
| 30/4/2021 | 07:00 | UKREG | Genedrive PLC COVID-19 PCR test approved by Indian regulator |
| 23/4/2021 | 10:02 | ALNC | Genedrive says study shows kit is effective at diagnosing Hepatitis C |
| 23/4/2021 | 07:19 | ALNC | *Genedrive says study shows HCV-ID Kit effective in diagnosing Hepatitis C |
| 23/4/2021 | 07:00 | RNSNON | Genedrive PLC Excellent performance data for Genedrive(R) HCV test |
1 Year Genedrive Chart |
Intraday Genedrive Chart |
